Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

  1. Shi-Lung Lin1,
  2. Donald C. Chang1,
  3. Samantha Chang-Lin1,
  4. Chun-Hung Lin2,
  5. David T.S. Wu3,
  6. David T. Chen3, and
  7. Shao-Yao Ying1
  1. 1Department of Cell and Neurobiology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA
  2. 2Dental Department, Taiwan Adventist Hospital, Taipei City 10556, Taiwan, Republic of China
  3. 3Department of Ear, Nose and Throat, Tzu Chi General Hospital, Hualien 970, Taiwan, Republic of China

Abstract

Renewal of stem cells differs from cancer cell growth in self-controlled cell division. The mir-302 microRNA (miRNA) family (mir-302s) is expressed most abundantly in slow-growing human embryonic stem (ES) cells, and quickly decreases after cell differentiation and proliferation. Therefore, mir-302s was investigated as one of the key factors essential for maintenance of ES cell renewal and pluripotency in this study. The Pol-II-based intronic miRNA expression system was used to transgenically transfect the mir-302s into several human cancer cell lines. The mir-302 – transfected cells, namely, miRNA-induced pluripotent stem (mirPS) cells, not only expressed many key ES cell markers, such as Oct3/4, SSEA-3, SSEA-4 ,Sox2, and Nanog, but also had a highly demethylated genome similar to a reprogrammed zygotic genome. Microarray analyses further revealed that genome-wide gene expression patterns between the mirPS and human ES H1 and H9 cells shared over 86% similarity. Using molecular guidance in vitro, these mirPS cells could differentiate into distinct tissue cell types, such as neuron-, chondrocyte-, fibroblast-, and spermatogonia-like primordial cells. Based on these findings, we conclude that mir-302s not only function to reprogram cancer cells into an ES-like pluripotent state but also to maintain this state under a feeder-free cultural condition, which may offer a great opportunity for therapeutic intervention.

Keywords

Footnotes

  • Reprint requests to: Shi-Lung Lin, Department of Cell and Neurobiology, Keck School of Medicine, BMT-403, University of Southern California, 1333 San Pablo Street, Los Angeles, CA 90033; e-mail: lins{at}usc.edu; fax: (323) 442-3466; or Shao-Yao Ying, Department of Cell and Neurobiology, Keck School of Medicine, BMT-403, University of Southern California, 1333 San Pablo Street, Los Angeles, CA 90033; e-mail: sying{at}usc.edu; fax: (323) 442-3466.

  • Abbreviations: miRNA, microRNA; mir-302s, the mir-302 family; ES, embryonic stem; iPS, induced pluripotent stem; mirPS, mir-302-induced pluripotent stem; EB, embryoid body; CSC, cancerous stem cell; Pol-II, RNA polymerase type-II; NMD, nonsense-mediated decay.

  • Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.1162708.

    • Received May 1, 2008.
    • Accepted July 15, 2008.
| Table of Contents